(R)-4-Propyl-4,5-dihydrofuran-2(3H)-one is a chiral lactone derivative, specifically a γ-lactone with a propyl substituent at the 4-position. It is a key chiral building block in organic synthesis, valued for its defined stereochemistry at the carbon adjacent to the carbonyl group. The compound is typically synthesized via asymmetric methods or enzymatic resolution to obtain the desired (R)-enantiomer. Its primary and most significant application is as a crucial chiral intermediate in the synthesis of various pharmaceutical agents. It serves as a core structural motif for constructing more complex molecules, particularly those targeting the central nervous system. For instance, it is a key precursor in the synthesis of certain GABA analogues and other bioactive compounds where the stereochemistry is critical for biological activity and receptor binding. As a versatile synthon, it is used in reactions such as ring-opening, alkylation, and further functionalization to introduce the chiral fragment into target molecules. It is commercially available from suppliers specializing in fine chemicals and chiral intermediates for pharmaceutical research and development.